The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation.
about
Burden of de novo malignancy in the liver transplant recipientIntestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin)The role of neutralizing antibodies for mouse mammary tumor virus transmission and mammary cancer development.Herpesvirus infections in organ transplant recipientsPersistent gamma-herpesvirus infections: what can we learn from an experimental mouse model?Pediatric intestinal transplantation: historical notes, principles and controversies.Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumorsEpstein-Barr virus-related lymphoproliferation in children after liver transplant: role of immunity, diagnosis, and management.Islet transplant: an option for childhood diabetes?Management of opportunistic infections in solid-organ transplantation.Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.Strategies for the prevention of infection after solid organ transplantation.Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary.Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivationPost-transplantation lymphoproliferative disorder (PTLD) twenty years after heart transplantation: a case report and review of the literature.Ocular post-transplant lymphoproliferative disorderQuantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients.Successful renal retransplantation after post-transplant lymphoproliferative disease.CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients.Recurrent Epstein-Barr virus associated disease in a cardiac transplant patient: evolution from plasmacytic hyperplasia to diffuse large cell lymphoma.Epstein-Barr virus infection and malignancy in solid organ transplant recipients: strategies for prevention and treatment.A 16-year multi-institutional study of the role of age and EBV status on PTLD incidence among pediatric heart transplant recipients.Comprehensive review of post-organ transplant hematologic cancers.Impact of antiviral prophylaxis in adults Epstein-Barr Virus-seronegative kidney recipients on early and late post-transplantation lymphoproliferative disorder onset: a retrospective cohort study.Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen.
P2860
Q26859216-0591B42C-BCBE-406C-AD33-D9B4C0F30675Q34291326-0DE75DB7-24CB-4FE6-BBD8-E7F21999214FQ34467281-F821094A-D6A6-4947-854C-D581955D83D3Q34579836-B8F668AB-9B7F-45EF-9615-D626F7BFA2E7Q34584067-78240764-2E4C-49EB-A0E0-ED7451D66464Q34722922-6E8FE8B8-4CC1-4CAE-AA5A-BCF6D650FF9AQ34767204-9923E42D-A790-4B28-9656-7747FC953624Q34861980-BA9A7841-7FDC-4FC4-86E8-41D8C61C94C4Q35159274-0BD64711-E54F-4034-AD09-C9C2C6D0F559Q35841369-F05E6D4A-B140-4CF8-9B9F-E02D215AC37EQ36556729-CDB7B5E0-7BC1-4C20-B0A2-10C4BB118DDDQ36670902-29D0E7A1-B8AC-4D86-AD87-30122C3A3778Q37252858-1FA96357-4D57-4E1D-873B-7B73770BF5D9Q37352087-79EAFDA1-D3A7-4C6A-AB93-0AF0E35AAD2FQ37730638-BD860E1A-C64A-4B22-9972-07BB5D3AC574Q42360100-2E21C785-DCB1-4039-8A47-862F813ED4D3Q44936481-89AFBA0E-6985-4B6A-B144-6ECE45A12DBEQ45100334-FBEE610E-CAF9-48E5-8970-A2C685A61017Q45413727-7F2ACE05-CD6C-4709-B43E-BC9581DED726Q45736977-294EE96A-D979-4740-A4DF-48ADA845163EQ45737028-14128E2A-16E2-45DB-9AC3-AA8DACBAF9D6Q46775538-0195EF13-689E-4158-9AF0-1C71BD91396DQ47572480-CEC8D6AF-6A9C-4EE6-BE50-80EDCDA948B4Q47604346-6B235121-F32A-4962-B46B-639F2EAE4719Q53251807-C7F978BF-0BAE-49D9-8A7A-4B35047B1345
P2860
The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The role of antiviral and immu ...... g solid organ transplantation.
@ast
The role of antiviral and immu ...... g solid organ transplantation.
@en
The role of antiviral and immu ...... g solid organ transplantation.
@nl
type
label
The role of antiviral and immu ...... g solid organ transplantation.
@ast
The role of antiviral and immu ...... g solid organ transplantation.
@en
The role of antiviral and immu ...... g solid organ transplantation.
@nl
prefLabel
The role of antiviral and immu ...... g solid organ transplantation.
@ast
The role of antiviral and immu ...... g solid organ transplantation.
@en
The role of antiviral and immu ...... g solid organ transplantation.
@nl
P2093
P1476
The role of antiviral and immu ...... g solid organ transplantation.
@en
P2093
P304
P356
10.1034/J.1399-3062.2001.003002097.X
P577
2001-06-01T00:00:00Z